Linden Peter CV Jan 2013

8/13/2019 Linden Peter CV Jan 2013

1/40

CURRICULUM VITAE

NAME: Peter Kenneth Linden, MD, DMD

HOME 512 Edgerton PlaceADDRESS: Pitts!rgh, PA 152"#

HOME PHONE: $%12& ''1(1)*1

+S-NESS: Alleghen. /eneral Hos0ital E(MA-L ADDRESS: 0linden0ahs3orgADDRESS: 4horacic and ardio6asc!lar S!rger.

Di6ision o7 S!rgical ritical are SPOSE: Mar. Anne NelsAlleghen. Pro7essional +!ilding%)" East North A6en!eS!ite 8")

Pitts!rgh, PA 15212

+S-NESSPHONE: $%12& 85)(''5' +S-NESS 9A: $%12& 85)(''58

EDUCATION AND TRAINING

UNDERGRADUATE

1)*"(1)*% R!tgers ollege +A (1)*% +iolog.Ne +r!nsic;, N)"(12>)5 ni6ersit. o7 Pitts!rgh Assistant Pro7essor School o7 Medicine De0art=ent o7 Anesthesiolog. Pitts!rgh, PA $Pri=ar. A00oint=ent&*>)"(12>)5 ni6ersit. o7 Pitts!rgh Assistant Pro7essor

School o7 Medicine De0art=ent o7 Medicine Pitts!rgh, PA $Secondar. A00oint=ent&

1>1>)'('>8">"2 ni6ersit. o7 Pitts!rgh Associate Pro7essor School o7 Medicine De0art=ent o7 Anesthesiolog. Pitts!rgh, PA $Pri=ar. A00oint=ent&

1>1>)'(8>") ni6ersit. o7 Pitts!rgh Associate Pro7essor School o7 Medicine De0art=ent o7 Medicine Pitts!rgh, PA $Secondar. A00oint=ent&

*>1>"2(2""5 ni6ersit. o7 Pitts!rgh Associate Pro7essor School o7 Medicine De0art=ent o7 ritical are MedicinePitts!rgh, PA $Pri=ar. A00oint=ent&

2""5(2"") ni6ersit. o7 Pitts!rgh Pro7essor School o7 Medicine De0art=ent o7

ritical are MedicinePitts!rgh, PA $Pri=ar.

A00oint=ent&

2"")32"11 Dreel ni6ersit. Pro7essor School o7 Medicine De0art=ent o7 Medicine

2"11(0resent 4e=0le ni6ersit. Ad!nct Pro7essor School o7 Medicine De0art=ent o7 Medicine

NON -ACADEMIC

1)*)(1)#" Dana(9arer ancer enter Research Assistant +oston, MA

)>#2(11>#2 Sancta Maria Hos0ital Sta77 Anesthesiologist a=ridge, MA

*>#)('>)" Best=oreland Hos0ital -ntensi6ist /reens!rg, PA

>6ar>>a00s>con6ersion>t=0>scratchC2>2125%#8#'3doc 2


3/40

*>)"(8>") PM ( Pres.terian ni63 Hos0ital -ntensi6ist, Li6er 4rans0lant - ritical are Medicine

Pitts!rgh, PA

*>)%(*>"1 PM ( Pres.terian ni63 Hos0ital Associate o(Director,ritical are Medicine M Li6er 4rans0lant - Ser6ice

Pitts!rgh, PA

*>)*(5>"% PM ( Magee(Bo=en@s Hos0ital -ntensi6istritical are MedicinePitts!rgh, PA

*>"1(8>") PM ( Pres.terian ritical are Medicine Director ritical are Medicine 4rans0lant - $4-&

Pitts!rgh, PA

8>")( Alleghen. /eneral Hos0ital Director S!rgical ritical areDe0art=ent o7 ardiothoracic S!rger.

Di6ision ritical are Medicine

8>")( Best Penn Alleghen. Health S.ste= Director ritical are Ser6ices

CERTIFICATION AND LICENSURE

SPECIALTY CERTIFICATION

National +oard o7 Dental Ea=iners 1)*#Northeast Regional +oard o7 Dental Ea=iners 1)#"

A=erican Societ. o7 Anesthesiolog. -n 4raining Ea= 1)#1A=erican Societ. o7 Anesthesiolog. -n 4raining Ea= 1)#2Di0lo=ate, National +oard o7 Medical Ea=iners 1)#5

A=erican +oard o7 -nternal Medicine 1)#*

Ad6anced ardiac Li7e S!00ort 1)##Ad6anced 4ra!=a Li7e S!00ort 1)#)A=erican +oard o7 -nternal Medicine>-n7ectio!s Disease 1))"A=erican +oard o7 -nternal Medicine>ritical are Medicine 1))1 $Recerti7ication: 5>"%&Ad6anced ardiac Li7e S!00ort 2"")

MEDICAL OR OTHER PROFESSIONAL LICENSURE

Dental ( Massach!setts $-nacti6e& 1)#"Medical ( Penns.l6ania $Acti6e& 1))8 ( Present9ederal DEA $Acti6e& 1))5 ( Present

HONORS

Henr. R!tgers Research Scholarshi0, R!tgers ollege 1)*8(*%No=ination 7or O!tstanding 9ac!lt. ritical are Medicine 1))1No=ination 7or O!tstanding 9ac!lt. ritical are Medicine 1))%No=ination 7or O!tstanding 9ac!lt. ritical are Medicine 1))5O!tstanding linical 4eacher Aard $ritical are Medicine& 1))5O!tstanding linician Aard $ritical are Medicine& 1))5No=ination 7or O!tstanding 9ac!lt., ritical are Medicine 1))*



4/40

President@s itation Aard 7or ontri!tions to SM 1))#linical 4rials Scholar Aard 1)))Strath=ore@s Bho@s Bho 2"""Leist Fisiting Pro7essorshi0, Ma.o linic,


5/40

Medical enter

E=erging 0atterns o7 antiiotic resistance3 ritical are Medicine Lect!re Series, ni6ersit. o7 Pitts!rghMedical enter

+ronchosco0ic techni!es 7or the diagnosis o7 nosoco=ial 0ne!=onia3 ritical are Medicine Lect!re Series3ni6ersit. o7 Pitts!rgh Medical enter

Diagnostic a00roach to 7e6er in the - setting3 ritical are Medicine Lect!re Series, ni6ersit. o7 Pitts!rghMedical enter

As0ects o7 -n7ection ontrol Practice in the -3 ritical are Medicine Lect!re Series, ni6ersit. o7 Pitts!rghMedical enter

Manage=ent o7 9!l=inant He0atic 9ail!re3 ritical are Medicine Lect!re Series, ni6ersit. o7 Pitts!rghMedical enter3

Bor;sho0 in -n7ectio!s Diseases3 ritical are Medicine 9ello Lect!re Series, ni6ersit. o7 Pitts!rghMedical enter3

Manage=ent o7 the riticall. -ll Patient ith hronic Li6er 9ail!re3 ritical are Medicine Lect!re Series,

ni6ersit. o7 Pitts!rgh Medical enter3

In+$,$+ual In"raural Pre&en"a"$on&

Se0te=er 1))% Diagnosis and Manage=ent o7 -n7ections in the -:Patho0h.siolog. Across the Li7es0an

$Masters N!rsing St!dents&


6/40

4 4eaching on7erenceAlleghen. /eneral Hos0ital

Ma. 2"") - Manage=ent o7 hronic Li6er 9ail!re/- /rand Ro!nds

Alleghen. /eneral Hos0ital

In+$,$+ual In"raural Pre&en"a"$on& .on"$nue+/*


7/40

1))% ( 1))# M!lticenter trial o7 S.nercid 7or the 4reat=ent o7 FRE9 -n7ection3 Rhone(Po!lenc RorerJ182,"""

1))% G 1))5 Anti7!ngal Pro0h.lais3 P7i?er, -nc3 J),)""

1))% se o7 oa?alidinone co=0o!nd 1""52) 7or the treat=ent o7 serio!s in7ection d!e to highle6el 6anco=.cin resistant E3 7aeci!=3 0ohn Phar=ace!tical J2',"""

1))5 /ran!loc.te(=onoc.te colon. sti=!lating 7actor $/MS9& as an ad!nct 7or thetreat=ent o7 se0sis3 -==!ne J1'","""

Gran"& ' E0!$re+ .on"$nue+/

1))' ( 1))* tili?ation o7 4echni(are as a thera0e!tic ad!nct 7or serio!s s!0er7icial and dee0 o!ndin7ection ith 6anco=.cin(resistant Enterococc!s 7aeci!= $FRE9&3 are 4ech -nc3 J%5,"""

1))' ( 1))* 4he e77ect o7 6anco=.cin(resistance on the cost o!tco=e o7 enterococcal actere=ia3 Rhone(Po!lenc Rorer J1","""

1))# Rando=i?ed e6al!ator lind co=0arati6e 0hase -- st!d. o7 iracin $SH 2*#))& 6s3 aco=ination o7 chlora=0henicol and do.c.cline in the treat=ent o7 6anco=.cin(resistant

enterococcal $FRE& actere=ia3 Schering(Plo!gh J5,"""

1))' G 1))# LI(88882# Dose escalation in 0atients ith gra=(0ositi6e actere=ia3 Eli Lill. Phar=ace!ticalsJ'","""

1))# G 1))) Phase 2 rando=i?ed, =!lticenter, do!le(lind, 0laceo(controlled st!d. to co=0are to doseso7 ra=o0lanin and 0laceo in the deconta=ination o7 the gastrointestinal s.ste= coloni?ed .Fanco=.cin(Resistant Enterococc!s 9aeci!= $FRE9&3 -ntraiotics J5","""

1)))(2""" Rando=i?ed dose co=0arati6e 0hase ii>iii st!d. o7 ?iracin $SH 2*#))& in the treat=ent o7serio!s in7ection d!e to 6anco=.cin(resistant enterococci3 Schering(Plo!gh J*#,"""

1)))(2""" Rando=i?ed st!d. o7 lo 6s3 high dose line?olid 7or the treat=ent o7 in7ection d!e to

6anco=.cin(resistant enterococci33 Phar=acia 0ohn J#","""

2"""(2""2 LI(88882# Dose Escalation in Patients ith /ra=(Positi6e +actere=ia d!e to Sta0h.lococc!sa!re!s3 Eli Lill. Phar=ace!ticals J%1,21%

2"""(2""2 Foricona?ole 7or andide=ia in Non(ne!tro0enic 0atients $A rando=i?ed, do!le(lind trial&P7i?er Phar=ace!ticals J*),1#%

2"""(2""2 Rando=i?ed st!d. o7 line?olid 6s3 6anco=.cin 7or actere=ia d!e to Sta0h.lococc!s a!re!s3Phar=acia 0ohn J)8, )5"

2"""(2""2 M!lticenter o0en(lael non(co=0arati6e st!d. to assess sa7et. and e77icac. o7 cidecin$da0to=.cin& in the treat=ent o7 s!ects ith in7ections d!e to gra=(0ositi6e acteria that are

resistant to 6anco=.cin, or ho are otherise re7ractor. to , or contraindicated 7or c!rrentl.a6ailale thera0.3 !ist Phar=ace!ticals J#1,%1#

2"""(2""2 A =!lticenter, o0en(lael rando=i?ed st!d. to co=0are the sa7et. and e77icac. o7 i6 cidecin$da0to=.cin& ith that o7 6anco=.cin in the treat=ent o7 actere=ic in7ections d!e to gra=(0ositi6e acteria3 Eli Lill. Phar=ace!ticals J*5,)""

2"""(2""8 LI(88882# Dose 9inding in S!ects ith S3 a!re!s actere=ia $H%(M(ARRM&3 Eli Lill.Phar=ace!ticals, J8#, *1%

2"""(2""8 National Heart L!ng and +lood -nstit!te R9P No3 NHL+-(HR("1("1 ARDSNE4 Pros0ecti6e(rando=i?ed =!lticenter trial o7 0!l=onar. arter. catheter 6s3 central 6eno!s catheter 7or



8/40

=anage=ent o7 res0irator. distress s.ndro=e and ac!te l!ng in!r. and 0ros0ecti6erando=i?ed 7l!id(lieral 6s3 7l!id conser6ati6e =anage=ent o7 ac!te l!ng in!r. and ac!teres0irator. distress s.ndro=e3 P-: Peter Linden, M3D3 o(P-: Michael Donahoe, M3D3, Mitchell9in;, M3D3 ontract N"1(HR(1'1523 J%*',""*

2""2(2""% Line?olid 6s Fanco=.cin>Oacillin>Dicloacillin in 4reat=ent3 Phar=acia J)8,)5"

2""%(2""' Ecor0 Medical +AL 7or Ac!te Li6er 9ail!re $++(-ND(*15*&

9ood and Dr!g Ad=inistration $P-:


9/40

Manage=ent O0tions in 9!l=inant He0atic 9ail!re3 4rans0lant Proc 28:1#)5(1#)#, 1))13

83 Linden P , /a.os;i 4, 9!i H, K!sne S3 -n6asi6e =.cosis in a li6er trans0lant reci0ient3 4rans0lantScience 2 $2&: **(*), 1))23

%3 ;ah 9, Merha6 H, Kra=er D, Eghtesad +, Sa=i=i 9, 9re??a E, Linden P, Mieles L, Sel. R: Earl.o!tco=e o7 li6er trans0lantation in 0atients ith a histor. o7 s0ontaneo!s acterial 0eritonitis3$Presented at the -F -nternational ongress o7 4rans0lantation Societ., Paris, 9rance, A!g!st 1'(

21, 1))2&3 4rans0lant Proc 25$1& +oo; -- 003 1118(1115, 1))83

Re(eree+ Ar"$le& .on"$nue+/

53 Mane? R, Bhite L, Linden P, K!sne S, Martin M, Kra=er D, De=etris A


10/40

1*3 Linden P , Pasc!lle AB, McDe6itt D, Kra=er Ddal7o0ristin on the o!tco=eo7 6anco=.cin(resistant Enterococc!s 7aeci!= acterae=ia: co=0arison ith a control cohort3 6ar>>a00s>con6ersion>t=0>scratchC2>2125%#8#'3doc 12


13/40


513 Ragha6an M, Linden P3 Ne treat=ent o0tions 7or co=0licated s;in and so7t tiss!e in7ections3 Dr!gs'% $15&: 1'21(1'%2, 2""%3

523 9inerg R, Moellering R, 4all. 9, raig B, Pan;e. /, Dellinger EP, Best M,


14/40


''3 Paterson DL, M!to A, Ndirang! M, Linden PK, Potos;i +A, a0itano +, +ono=o RA, Aron D,Dons;e. ta?oacta= 6ers!s ce7e0i=e(containing antiiotic regi=ens3

'*3 Anti=icro Agents he=other 52$2&: %'5(%'), $9e& 2""#3 $E0!lished, No6e=er 1), 2""*&3

'#3 Aggaral S, +roo;s DM, Kang I, Linden PK, Pat?er


15/40

#13 Parsons E, Ho!gh L, Se.=o!r B, oo;e R, R!en7eld /D, Bat;ins 4R3 NHL+- ARDSNetoor;3 Red lood cell trans7!sion and o!tco=es in 0atients ith ac!te l!ng in!r, se0sis andshoc;3 rit are 2"1115 R221

#23 ler=ont /, Kong L, Beiss7eld LA, La6e


16/40

l.=0ho0roli7erati6e Disease in E0stein(+arr seronegati6e ad!lt li6er trans0lant reci0ients3 Presentedto the Sith ongress o7 E!ro0ean Societ. 7or Organ 4rans0lantation3 $S.=0osi!=&3

1"3 Linden P3 00er and loer res0irator. tract in7ection3 -n Ronco and +ello=o R $eds&3 ritical areNe0hrolog. Kl!er Acade=ic P!lishers, Dordrecht, 4he Netherlands 1))# Section *31, 00 %21(%%"3

113 Linden P3 Section Editor((Section * -n7ections in -ntensi6e are Patients3 -n ritical areNe0hrolog. 3 Ronco and R3 +ello=o $eds&3 Kl!er Acade=ic P!lishers, Dordrecht, 4heNetherlands 1))#3

123 Linden P3 -n7ections a7ter solid organ trans0lantation $ha0ter '%&3 -n: Shoe=a;er B, A.res SM,/ren6i; A, Holroo; PR $eds& 4etoo; o7 ritical are Medicine %th Edition B+ Sa!nders,Philadel0hia, PA3 2""" 00 *81(*%53

183 Linden P3 -n7ections in Li6er 4rans0lant Reci0ients3 -n: Manage=ent o7 -n7ections in-==!noco=0ro=ised Patients3 $Eds M3 /la!ser, P3 Pi??o&3 Harco!rt P!lishers, London2"""ha0ter *32 00 2)5(8223

1%3 Nichols R3 Martone B


17/40

2'3 Aldaagh 4, Milrandt E+, Linden PK3 Steroids in earl. ARDS $M >3decisions!00ortin=edicine3co=>a!thoror;7lo>inde30h0

883 Linden P3 S!rgical co=0lications 7olloing solid organ trans0lantation3 -n: Princi0les and Practiceso74rans0lant -n7ectio!s Diseases $S0ringer& in 0ress

Publ$e+ Ab&"ra"&

13 Linden P , Stein KL, Kor=os R, /ri77ith +, Ar=itage 6ar>>a00s>con6ersion>t=0>scratchC2>2125%#8#'3doc 17
http://www.decisionsupportinmedicine.com/authorworkflow/index.phphttp://www.decisionsupportinmedicine.com/authorworkflow/index.phphttp://www.decisionsupportinmedicine.com/authorworkflow/index.php


18/40

Publ$& #e+ Ab&"ra"& .on"$nue+/

53 Linden P , Pasc!lle AB, Mane? R, Kra=er D, Martin M3 9ail!re o7 oral do.c.cline to eradicate 7ecalcarriage o7 6anco=.cin resistant enterococc!s 7aeci!=3 Proc o7 the A=erican Societ. 7orMicroiolog., Astract L(2#, 0age 522, Ma. 1))23

'3 Linden P , Ang!s D, hell!ri L, Dottereich L, Pins;. M3 H!=an anti(endotoin antiod. $HA(1A& 7orgra= negati6e se0sis: !=!lati6e e0erience o6er a 15 =onth 0eriod at a single instit!tion3Presented at ASA Meetings, Ne Orleans, LA, Se0te=er, 1))23

*3 Linden P , Mane? R, +reinig MK, 4orre(isneros


19/40

Publ$e+ Ab&"ra"& .on"$nue+/

1*3 Linden P , Pasc!lle AB, Mane? R, Kra=er D6ar>>a00s>con6ersion>t=0>scratchC2>2125%#8#'3doc 19


20/40


2#3 Pose. K, Po;r.;a M, Kr.sto7ia; S, Mco. +, Bing E, R!en 9, Linden P, Kra=er D3 4he o=inedE77ects o7 ohorting, Signage, Ed!cation, and En6iron=ental ontrol on Fanco=.cin ResistantEnterococc!s 7aeci!= $FRE9& in -ntensi6e are Patients3 Presented to AP- 21st Ann!alEd!cational and -nternational on7erence3 incinnati, OH, Ma., 1))%3 A= < -n7 ontrol 22 $2&:1))%3

2)3 Linden P , Pasc!lle AB, Riddler S, Sil6er=an A, Dean


21/40


%"3 Linden P , Pasc!lle AB, Kra=er Ddal7o0ristin $RP 5)5""& onclinical and acteriologic o!tco=e o7 6anco=.cin(resistant Enterococc!s 7aeci!= actere=ia:o=0arison ith a control cohort3 Presented to 8rd -nternational on7erence on the =acrolides,a?alides and stre0togra=ins, Lison, Port!gal,


22/40


583 Kr.sto7ia; S, Linden PK, K!sne S3 Monitoring and control o7 as0ergillosis in a trans0lant center3 Proco7 Association 7or Pro7essional -n7ection ontrol and E0ide=iolog. $AP-& =eetings, Ne Orleans,LA,

5%3 Ma?ariegos /F, Linden P, Pinna A, Kra=er D, Ash SR, Pat?er dal7o0ristin $RP 5)5"", S.nercid& 7or the treat=ent o7 6anco=.cin(resistant Enterococc!s7aeci!= $FRE9& in an ongoing e=ergenc. !se 0rogra=3 Progra= and Astracts o7 %th -MAS=eeting, astract 231%, 03 8"3 +arcelona, S0ain, dal7o0ristin3 Progra= and Astracts o7 %th to -nternationalongress o7 Macrolides, A?alides, and Stre0togra=ins $-MAS&, astract 231*, 03 813 +arcelona,S0ain, 6ar>>a00s>con6ersion>t=0>scratchC2>2125%#8#'3doc 22


23/40


'53 Linden P , Pasc!lle B3 E77ect o7 a !inolone S!stit!tion Polic. on the Acc!rac. o7 E=0iric!inolone se 7or - Patients3 Societ. o7 ritical are Medicine, Ann!al Meeting, San Antonio,4, 9er!ar. 1))#&3 rit are Med 2' $1&: Astract 8%2, 00A182, 1))#3

''3 -to < 7or the LEAR Steering o==ittee3 Res!lts 7ro= the lear $ollaorati6e Echange o7Anti7!ngal Research& Progra= Anal.sis o7 )2) 0atients3 Proceedings o7 9oc!s on 9!ngal -n7ections,Orlando, 9lorida, March, 1))#3

'*3 Linden P , Rosenloo= A, dal7o0ristin $RP 5)5"", S.nercid& 7or the treat=ent o7 6anco=.cin(resistant Enterococc!s7aeci!= $FRE9& in7ections in an ongoing e=ergenc. !se 0rogra=3 $Poster 0resentation& Proceedingso7 the #th -nternational Societ. o7 -n7ectio!s Diseases, +oston, MA Ma. 15(1#, 1))# Astract

5)3"1* Page 2""

*"3 Linden P , Kr.sto7ia; S, Ma?ariegos /, Pinna AD3 tili?ation o7 the to0ical =icroicide 4echni(areas a thera0e!tic ad!nct 7or intraado=inal in7ection ith 6anco=.cin resistant Enterococc!s 7aeci!=$FRE&3 $Poster 0resentation& #th -nternational ongress o7 -n7ectio!s Diseases, +oston, MA, Ma. 15(1#, 1))# Astract )83"2) Page 818 3

*13 Linden P , Paladino 6ar>>a00s>con6ersion>t=0>scratchC2>2125%#8#'3doc 23


24/40


**3 Linden P , ole. K, Kra=er Ddal7o0ristin co=0assionate !se 0rogra= 7or the treat=ent o7 gra= 0ositi6e in7ections3$Presented to - Meetings, +ir=ingha=, England,

#"3 Kra=er D6ar>>a00s>con6ersion>t=0>scratchC2>2125%#8#'3doc 24


25/40


#)3 Linden P, ole. K, K!sne S3 +acteriologic e77icac. o7 nitro7!rantoin 7or the treat=ent o7 !rinar. tractin7ection d!e to 6anco=.cin(resistant E 7aeci!=3 8*thAnn!al Meeting o7 the -n7ectio!s DiseasesSociet. o7 A=erican $-DSA&, Philadel0hia, PA No6e=er 1'(2", 1)))3 lin -n7ect Dis 2)$%& : ))),1)))3

)"3 Fergis M, Ha.den MK, ho 6ar>>a00s>con6ersion>t=0>scratchC2>2125%#8#'3doc 25


26/40


1"13 Fergis EN, Ha.den MK, ho


27/40


1183 4ho=0son +4, +roer R, Bheeler A, Biede=ann H, Schoen7eld D, +ernard / 7or the NHL-+->ARDSNetor;3 Standard are Prior to Entr. into ARDS Netor; st!dies enco=0assed ide 6ariation intidal 6ol!=es $Ft& and Platea! Press!re $P0lat&3 $Acce0ted 7or 0oster 0resentation to ))th-nternational on7erence o7 the A=erican 4horacic Societ. $A4S& Seattle, BA Ma. 1'(21, 2""8&3

A= Re6 Res0 M 1'* $*(S!00le=ent&: Astract ")*, 00 A*8#, 2""83

11%3 Paterson DL, McKinnon


28/40


12%3 Linden P, Sarani +3 +lisard D3 Acti6ated 0rotein 7or se6ere se0sis in ado=inal organ trans0lantreci0ients3 Proceedings o7 the Borld 4rans0lant ongress, +oston, MA

2"(28, 2""*& Li6er 4rans0lantation 18 $S1&: Astract 1*2, 0age S1113

12*3 Linden P , Aggaral S, S0iro R, Sha;il O, Planinsic R, Marcos A3 O!tco=e o7 a =anage=ent0rotocol 7or intracranial h.0ertension in 7!l=inant he0atic 7ail!re ith e0id!ral =onitoring,7reco=inant actor F-- and h.0other=ia3 $Presented at -L4S =eeting, Rio de

'3 Linden, P3 -n7ection a7ter solid organ trans0lantation: An asol!te s!ccess and a still a relati6e0role= JEditorial3 < -nt are Med 12:1'8(1'5, 1))*3

*3 Linden P 3 Enterococcal in7ection in the -: On the 0reci0ice o7 a 0ost(antiiotic era $Editorial&3 6ar>>a00s>con6ersion>t=0>scratchC2>2125%#8#'3doc 30


31/40

Se$nar& an+ In,$"e+ Le"ure$!& .on"$nue+/

8*3 !rrent challenges in =.cotic in7ection in li6er reci0ients3 ni6ersit. o7 Bashington 4rans0lantDi6ision3 Seattle BA, Se0te=er 22, 1))#3

8#3 4he 9!t!re o7 the 4reat=ent o7 Serio!s /ra=(Positi6e -n7ections3 8#th Ann!al -nterscienceon7erences on Anti=icroial Agents and he=othera0., San Diego, A, Se0te=er 2%, 1))#3

8)3 Post(4rans0lant 9!ngal -n7ection3 Role o7 li0id 7or=!lations3 State ni6ersit. o7 Ne Ior;(Donstate, +roo;l.n, NI, Octoer 1%, 1))#3

%"3 S!r6eillance and =onitoring o7 0ost(trans0lant in7ection3 ni6ersit. o7 ali7ornia at San Diego34rans0lant /rand Ro!nds, San Diego, A, Octoer 2", 1))#3

%13 Manage=ent o7 =.cotic in7ection in li6er reci0ients3 ni6ersit. o7 ali7ornia at San Diego3He0atolog. /rand Ro!nds, San Diego, A, Octoer 2", 1))#3

%23 Ad6ances in the treat=ent o7 7!ngal in7ections in the solid organ trans0lant 0atient3 ali7ornia Societ.o7 Health(S.ste= Phar=acists, Anahei=, A, Octoer 2%, 1))#3

%83 Post(S!rgical o=0lications: Old hallenges, Ne Directions3 A=erican ollege o7 S!rgeonsSatellite Dinner S.=0osi!=, Orlando, 9lorida, Octoer 25, 1))#3

%%3 Realities o7 Resistance3 S.=0osi!= Disc!ssion3 -n7ectio!s Diseases Societ. o7 A=erica3 Den6er,O, No6e=er 12, 1))#3

%53 4reat=ent o7 Resistant /ra=(Positi6e -n7ections: 4he Role o7 !in!0ristin>Dal7o0ristin3 BesternPaci7ic Anti=icroial on7erence, K!ala L!=0!r, Mala.sia, Dece=er 2, 1))#3

%'3 Hos0ital(ac!ired gra=(0ositi6e in7ection3 Da.rea; Session, Societ. o7 ritical are Medicine, San9rancisco, A,



32/40


5*3 E=erging /ra=(0ositi6e 0athogens in li6er trans0lantation3 ni6ersit. o7 ali7ornia 4rans0lantation/rand Ro!nds, Los Angeles, A3

5#3 Ne thera0e!tic o0tions 7or the =anage=ent o7 0ost(trans0lant gra=(0ositi6e in7ection3 StrongMe=orial Hos0ital, ritical are on7erence, Rochester, Ne Ior;, Se0te=er 1', 1)))3

5)3 /ra=(0ositi6e resistance in the net =illeni!=3 Panel disc!ssant3 -nterscience on7erence onAnti=icroial agents and che=othera0., San 9rancisco, A, Se0te=er 2', 1)))3

'"3 /ra=(0ositi6e in7ection in solid organ reci0ients3 St3 FincentTs Hos0ital, /rand Ro!nds, Los Angeles,A, Se0te=er 8", 1)))3

'13 /ra=(0ositi6e in7ection in solid organ reci0ients3 edar Sinai Medical enter, Los Angeles, A,Se0te=er 8", 1)))3

'23 E=ergence o7 gra=(0ositi6e and gra=(negati6e in7ections in the intensi6e care !nit3 F- Encontro-nternacional de 4era0ia -ntensi6a do Rio de


33/40


*'3 /reater +alti=ore Medical enter3 /ra= 0ositi6e nosoco=ial in7ection and ne treat=ent o0tions3+alti=ore, MD, March 8, 2"""3

**3 E0ide=iolog. and o!tco=e o7 gra=(0ositi6e in7ection3 -n7ectio!s Disease /rand Ro!nds3 SNIDonstate Medical enter, +roo;l.n, Ne Ior;, March 1%, 2"""3

*#3 Pre6ention and 4reat=ent o7 Solid Organ Post(4rans0lant -n7ection: Past, Present and 9!t!re3Att!alita e ontro6ersie in 4era0ie Antiin7etti6a, Ferona, -tal., March 25, 2"""3

*)3 S!r6eillance and 0re6ention o7 in7ection in the solid organ reci0ient3 4rans0lantation /rand Ro!nds,4e=0le ni6ersit., Philadel0hia, PA, A0ril *, 2"""3

#"3 Ne o0tions 7or the treat=ent o7 7!ngal in7ection in the organ reci0ient3 !ddhi 4rans0lantation-nstit!te, O;laho=a it., OK, A0ril %, 2"""3

#13 /ra=(0ositi6e e0ide=iolog., 0resentation and thera0.3 4rans0lantation /rand Ro!nds, ni6ersit. o7North arolina Medical enter, A0ril 12, 2"""3

#23 Manage=ent o0tions 7or serio!s 7!ngal in7ection in the solid organ reci0ient3 /rand Ro!nds, St3Fincent@s Medical enter, Los Angeles, A, A0ril 1%, 2"""3

#83 se o7 Line?olid 7or FRE in7ection in solid organ reci0ients3 A=ercian Societ. o7 4rans0lantation,Satellite S.=0osi!=3 hicago, -L, Ma. #, 2"""3

#%3 E0ide=iolog. and Manage=ent o7 M!ltiresistant /ra=(Positi6e -n7ection in the Solid OrganReci0ient3 S!rgical on7erence, ni6ersit. o7 Minnesota $9air6ie& Medical enter, Minnea0olis,MN,

#'3 M!ltiresistant /ra=(Positi6e -n7ections in the Solid Organ 4rans0lant Patient3 ni6ersit. o7 Neras;aMedical enter, 4rans0lant Research on7erence, O=aha, Neras;a, Octoer 1#, 2"""3

#*3 /ra= Positi6e -n7ection in the Solid Organ Reci0ient3 Satellite S.=0osi!= to A=erican ollege o7S!rgeons3 hicago, -L, Octoer 21, 2"""3

##3 Manage=ent o7 Nosoco=ial and o==!nit.(Ac!ired 9!ngal -n7ections3 Kaiser(Sacra=entoHos0itals3 No6e=er #, 2"""3

#)3 E0ide=iolog., Presentation and Manage=ent o7 M!ltiresistant /ra=(Positi6e -n7ection in the SolidOrgan 4rans0lantation Reci0ient3 4rans0lant /rand Ro!nds, Ma.o linic, Rochester, MN, No6e=er1%, 2"""3

)"3 Li0id 9or=!lations o7 A=0hotericin +3 Phar=acolog.(4rans0lant on7erence3 ni6ersit. o7 hicagoMedical enter3 hicago, -L, No6e=er 21, 2"""3

)13 Diagnostic Dile==as 7or the Detection o7 /ra=(Positi6e -n7ection in the - Patient3 4hird-nternational Meeting on the 4hera0. o7 -n7ections3 9lorence -tal., Dece=er %(', 2"""3

)23 !in!0ristin>Dal7o0ristin: 4he Ne 4hera0e!tic O0tion 7or the 4reat=ent o7 Serio!s /ra= Positi6e-n7ections3 4hird -nternational Meeting on the 4hera0. o7 -n7ections, 9lorence, -tal., Dece=er %(',2"""3

)83 Manage=ent o7 serio!s gra=(0ositi6e in7ection in organ trans0lant reci0ients3 4rans0lant Researchon7erence, 9air6ie Medical enter, ni6ersit. o7 Minnesota, Minnea0olis, MN, 6ar>>a00s>con6ersion>t=0>scratchC2>2125%#8#'3doc 33


34/40


)%3 /ra=(negati6e acilli3 Still a Prole= S.=0osi!= on Recent De6elo0=ents in -n7ectio!s Diseases38"thSociet. o7 ritical are Medicine Meetings, San 9rancisco, 9er!ar. 1", 2""13

)53 Manage=ent o7 /ra=(Positi6e -n7ection in the Li6er 4rans0lant Reci0ient3 Li6er 4rans0lant /randRo!nds3 ni6ersit. o7 Mia=i, March 2#, 2""13

)'3 E0ide=iolog. o7 9!ngal -n7ection in Solid Organ 4rans0lants3 Societ. 7or Hos0ital E0ide=iolog.

Association, National 9o!ndation 7or -n7ectio!s Diseases, 4oronto, A, March 81, 2""13

)*3 Nosoco=ial -n7ection in riticall. -ll Patients3 Ne 4hera0e!tic O0tions 7or /ra=(Positi6e -n7ection3Societ. 7or Health are E0ide=iolog. Association3 National 9o!ndation 7or -n7ectio!s Diseases34oronto, A3 A0ril 2, 2""13

)#3 Manage=ent o7 Resistant /ra=(Positi6e -n7ection in the -3 ritical are /rand Ro!nds3ol!=ia Pres.terian ni6ersit. Hos0ital, Ne Ior;, NI, Ma. 1*, 2""13

))3 -n7ection in Solid Organ 4rans0lant Reci0ients((Past, Present, and 9!t!re3 -n7ectio!s Diseaseson7erence3 Me=orial Sloan Kettering Hos0ital Ne Ior; it., NI, Ma. 8", 2""13

1""3 Nosoco=ial /ra=(Positi6e -n7ection3 E=erging 4hera0ies on the Hori?on3 A=erican ollege o7

hest Ph.sicians, Philadel0hia, PA, No6e=er ', 2""13

1"13 Anti=icroial Resistance: Does it Ma;e a Di77erence3 Societ. o7 ritical are Medicine, San Diego,A ,


35/40


1123 4hera0. o7 serio!s 7!ngal in7ection in solid organ trans0lantation3 4rans0lantation /rand Ro!nds,Medical ollege o7 Firginia, Rich=ond, FA, Ma. 15, 2""83

1183 Anti=icroial !se in the criticall. ill3 SM +oard Re6ie o!rse, hicago, -L, Se0te=er *, 2""83

11%3 Manage=ent o7 the solid organ reci0ient3 SM +oard Re6ie o!rse, hicago, -L, Se0te=er *,2""83

1153 - Manage=ent o7 the =arginal li6er reci0ient F-- ongresso Na?ionale, Societa -taliana di4era0ia -ntensi6a, Paler=o, Sicil., Se0te=er 2', 2""83

11'3 - =anage=ent o7 ac!te li6er 7ail!re3 ni6ersit. Pol.clinic, De0t o7 Anesthesiolog., Paler=o,Sicil., Octoer 2, 2""83

11*3 onte=0orar. =anage=ent o7 7!ngal in7ections in the solid organ trans0lant reci0ient3 ME Se=inar:onte=0orar. Manage=ent o7 S.ste=ic 9!ngal -n7ections: Rationale Dr!g Selection 7ro= 4he Milie!o7 hoices3 Ohio Northern ni6ersit., ol!=!s, OH, Octoer 1"(11, 2""83

11#3 Manage=ent o7 e=erging 0role=s in 0ost(trans0lant in7ection3 ni6ersit. o7 Rochester, StrongMe=orial Hos0ital, /rand Ro!nds, No6e=er 1%, 2""83

11)3 hanging e0ide=iolog. and =anage=ent o7 0ost(trans0lant 7!ngal in7ection3 ni6ersit. o7 -ndianaDe0art=ent o7 4rans0lantation, Noon on7erence, Dece=er ), 2""83

12"3 Ne thera0ies 7or the =anage=ent o7 serio!s 7!ngal in7ection 7olloing li6er trans0lantation3ni6ersit. o7 Bisconsin, Madison, B-3 4rans0lant /rand Ro!nds, 9er!ar. ), 2""%3

1213 Fentilator(Associated Pne!=onia3 Post /rad!ate Re6ie o!rse3 88 rdritical are ongress,Societ. o7 ritical are Medicine, Orlando, 9L, 9er!ar. 2", 2""%3

1223 E=erging -n7ections: Best Nile, Mon;e.0o, SARS, FRSA3 Post /rad!ate Re6ie o!rse: riticalare((2""8 Literat!re Re6ie3 88rdritical are ongress, Societ. o7 ritical are Medicine,Orlando, 9L, 9er!ar. 21, 2""%3

1283 O0ti=i?ing se o7 olistin3 0date on Serio!s /ra= Negati6e +acterial -n7ections in the -: -s this

the tr!e end o7 the antiiotic era ni6ersit. o7 Pitts!rgh Medical enter, Pitts!rgh, PA, Ma. #,2""%

12%3 tilit. o7 the Platelia Assa. 7or the Diagnosis o7 as0ergillosis in solid organ trans0lant reci0ients3 2""%Medical ollege o7 Firginia, Rich=ond, FA, Ma. 2%, 2""%

1253 - Manage=ent o7 Solid Organ 4rans0lant Reci0ients3 Societ. o7 ritical are Medicine +oardRe6ie or!se, hicago, -L, A!g!st 2""%3

12'3 Antiiotic !se in critical illness3 Societ. o7 ritical are Medicine +oard Re6ie o!rse, hicago, -L,A!g!st 2""%3

12*3 olistin: An Old Dr!g ith a Ne 9!t!re %2nd-nterscience con7erence on Anti=icroial Agents and

he=othera0., Bashington, D, Octoer 81, 2""%3

12#3 Manage=ent o7 the criticall. ill li6er trans0lant candidate and reci0ient3 8%thSociet. o7 ritical areMedicine ongress, Phoeni, A,


36/40


1813 E0ide=iolog. and =anage=ent o7 7!ngal in7ection in the solid organ reci0ient3 4rans0lant /randRo!nds, Lahe. linic, +!rlington, MA, March 1", 2""53

1823 Manage=ent o7 li6er 7ail!re in the criticall. ill3 Merc. Medical enter, Medicine /rand Ro!nds,PM Merc., Pitts!rgh, PA, A0ril 21, 2""53

1883 E0ide=iolog., 0resentation and treat=ent o7 7!ngal in7ection a7ter solid organ trans0lantation3ni6ersit. o7 ali7ornia(-r6ine, 4rans0lant /rand Ro!nds,

18%3 Old and ne 6iral in7ections 7olloing trans0lantation3 -nternational S.=0osi!=: One 4ho!sandOrgan 4rans0lantations in the 9ri!li(Fene?ia /i!lia Region3 -talian National o==ission 7orontin!o!s Medical Ed!cation, dine, -tal., Octoer 2#(2), 2""53

1853 Firal, acterial and 7!ngal in7ections 7olloing li6er trans0lantation: E=erging threats3 Progra7tS!==it S.=0osi!=, 9!;!o;a, 1%53 Manage=ent o7 7!l=inant he0atic 7ail!re3 E=ergenc. Medicine /rand Ro!nds, ni6ersit. o7Pitts!rgh Medical enter3 Pitts!rgh, PA,

1%'3 E0ide=iolog. and =anage=ent o7 candide=ia3 Best=oreland Regional Hos0ital Medical /randRo!nds3 /reens!rg, PA, A0ril 2""#3

1%*3 E0ide=iolog. and =anage=ent o7 candide=ia3 Latroe Hos0ital Medical /rand Ro!nds3 Latroe,PA, A0ril 2""#3

1%#3 E0ide=iolog. and =anage=ent o7 candide=ia3 9ric; Hos0ital Medical /rand Ro!nds, Mt3 Pleasant,PA, Ma. 28, 2""#3

1%)3 E0ide=iolog. and =anage=ent o7 candide=ia3 Ridle. Par; Hos0ital, Ridle. Par;, PA, Ma. #, 2""#3



37/40


15"3 E0ide=iolog. and =anage=ent o7 candide=ia3

O"#er Re&ear# Rela"e+ A"$,$"$e&

Journal Re(eree$n%

Year Journal

1))1 ( Present ritical are Medicine1))2


38/40

1))% 4etoo; o7 ritical are Medicine ( Societ. 7or ritical are Medicine 8rd Edition3 Sa!nders $Section editor ( -n7ectio!s Diseases&

1))5 ritical are Ne0hrolog. ( Section Editor, -n7ectio!s Diseases Kl!er Acade=ic P!lishers $in 0rod!ction&

E+$"or$! ' Boo1& .on"$nue+/

2""" 4etoo; o7 ritical are Medicine ( Societ. 7or ritical are Medicine %th Edition3 Sa!nders $Section Editor ( -n7ectio!s Diseases U 4rans0lantation&

2""2 -==!nolog. and -n7ectio!s Diseases $Kl!er Acade=ic P!lishers&2""2 9!nda=entals o7 ritical are S!00ort $o!rse 4et, 4hird Edition&,

Societ. o7 ritical are Medicine2""8 -n7ection and Se0sis in the - $+ios P!lishing&

Gran" Re,$e)$n%2O"#er Peer Re,$e) A"$,$"3

1))8 ritical are Di6ision Research> linical 4rials Progra=( De0t3 Anesthesiolog. PM1))5 o=0etiti6e Medical Research 9!nd $ni6ersit. o7 Pitts!rgh O77ice o7 Research&1))5 4est !estion Re6ieer 7or A+-M G -n7ectio!s Diseases Ea=ination1))) Session Moderator, -nternational Li6er 4rans0lant Societ. $-L4S& Meeting, Pitts!rgh, PA1))) Moderator, Poster Session on Nosoco=ial -n7ections, SM2""" Session Moderator, -MASKO, Se6ille, S0ain

1))2 ( 1))5 hair=an, Antiiotic S!co==ittee ni6ersit. o7 Pitts!rgh Medical enter

Co$""ee Meber$!&*

1))"(2"") Phar=ac. and 4hera0e!tics o==ittee

ni6ersit. o7 Pitts!rgh Medical enter

1))2(2"") Hos0ital -n7ection o==ittee ni6ersit. o7 Pitts!rgh Medical enter

1))2(2"") - ost ontain=ent o==ittee

1))2(2"") Dr!g Ad6isor. Progra= Steering o==ittee

1))2(2"") Fanco=.cin Resistant Enterococc!s 9aeci!= 4as; 9orce

1))2(2"") Fanco=.cin Resistant Enterococc!s 9aeci!= Pre6ention o==ittee

1))2(2"") Dr!g Re0resentati6e 4as; 9orce

1))8(2"") Dr!g ost ontrol o==ittee

1))8(2"") M Ed!cation o==ittee

1))%(2"") - Phar=ac. ost Red!ction o==ittee

1))%(2"") Prod!ct Line Ser6ice o==ittee 7or Renal and Li6er 4rans0lantation

1))5(2"") ritical are Phar=ac. 4as; 9orce

1))5(2"") - ost E77ecti6eness o==ittee



39/40

1))5(2"") linical 4rials Progra=> Anesthesiolog. De0art=ent

1))'(2"") Scienti7ic A77airs o==ittee > Anesthesiolog. De0art=ent

1))#(2"") Antiiotic onsens!s Panel

1))#(2"") Antiiotic S!co==itte PM

1))#(2"") Patient are o==ittee $PM&

2""2(2"") Pro=otions and 4en!re o==ittee $PM(De0t o7 ritical are Medicine&

2""8(2"") -nter6ieer, Medical St!dent Ad=issions G ni6ersit. o7 Pitts!rgh School Medicine

2""*(2"") Pro=otions o==ittee $Non(ten!red 7ac!lt.& ni6ersit. o7 Pitts!rghSchool o7 Medicine

2""#(2"") ni6ersit. o7 Pitts!rgh Medical enter, +io=edical -nstit!tional Re6ie +oard

2"")( Res!scitation o==ittee, Alleghen. /eneral Hos0ital

2"")( hair=an, ritical are o==ittee, Alleghen. /eneral Hos0ital

2"")( FAP(HAP Re6ie o==ittee, Alleghen. /eneral Hos0ital

2"")( !alit. Manage=ent o==ittee, Alleghen. /eneral Hos0ital

2"") 4rans0lant o==ittee, Alleghen. /eneral Hos0ital

2"1"( S- A o==ittee, Alleghen. /eneral Hos0ital

2"11( Ethics o==ittee, Alleghen. /eneral Hos0ital2"1" Fal!e Anal.sis o==ittee, Alleghen. /eneral Hos0ital2"1" -n7ection ontrol o==ittee, Alleghen. /eneral Hos0ital2"11 Donor Ad6isor. /ro!0 , Alleghen. /eneral Hos0ital

23 P#araeu"$al4 Con"ra"e+ Con&ul"an"$!&

Rhone Po!lenc Rhorer A6entis Phar=ace!ticals Phar=acia 0ohn Lill. Phar=ace!ticals -ntraiotics Schering(Plo!gh !ist Phar=ace!ticals /eno=e 4hera0e!tics A=gen

-nter=!ne En?on Phar=ace!ticals P7i?er

83 Na"$onal Co$""ee&4 Con&ul"a"$on$!&

1))' Societ. o7 ritical are Medicine, Practice /!ideline o==ittee 9e6er Bor;!0 in the -ntensi6e are nit

1))' ollaorati6e Echange o7 Anti7!ngal Research $LEAR& Ad6isor. o==ittee Li0oso=e -nc3 Princeton, Ndal7o0ristin NDA

1))* Eli(Lill. Phar=ace!tical ons!ltationshi0 7or de6elo0=ent o7 FRE actere=ia 0rotocol 7or LI(8888)#

1))# Societ. o7 ritical are Meeting Planning o==ittee San Diego A

1))# St!d. Monitor 7or Phase % Dose(Ranging Pros0ecti6e 4rial o7 S.nercid 7or the 4reat=ent o7 FRE -n7ection

1))) Phar=acia and 0ohn3 Anti6iral dr!g de6elo0=ent3

1))) Hos0ital -n7ection ontrol Ad6isor. o==ittee 9oc!s /ro!0 7or SM

1))) enters 7or Disease ontrol and Pre6ention3 9oc!s /ro!0 on Antiiotic Rotation

1))) National 9o!ndations 7or -n7ectio!s Diseases, Planning o==ittee 7or Anti=icroial ResistanceMeeting +ethesda, Mar.land

2""" O!tco=es Scienti7ic Ad6isor. /ro!0 $DP> -ntraiotics&

2""1 Sta0h.lococc!s a!re!s Faccination Progra= Ad6isor. Panel3 $Nai Phar=ace!ticals&

2""1 ( 2""% Societ. o7 ritical are Medicine Re7resher o!rse o==ittee

2""1 Data Sa7et. Monitoring +oard $Ra=o0lanin S!00ression o7 FRE in Ne!tro0enia&

2"") Health and H!=an Ser6ices, Health Reso!rces Ser6ice Ad=inistration Ad6isor. o==ittee onOrgan 4rans0lantation

Linden Peter CV Jan 2013

Documents

Transcript of Linden Peter CV Jan 2013